Biomedicine and Pharmacotherapy

Displaying 1 - 6 of 6
Lado, W., Wu, X., Choi, S., Dong, Y., Yang, G., Arancio, O., Tempia, F., Miniaci, M. C., Sulzer, D., Mosharov, E., & Tang, G. (2025). Synaptic plasticity deficits in a mouse model of Timothy syndrome: LTP saturation and its pharmacological rescue by nifedipine. Biomedicine & Pharmacotherapy, 184, 117896. https://doi.org/10.1016/j.biopha.2025.117896
Publication Date
Saha, N., Lee, S. G., Brockmann, E.-C., de la Cruz, M. J., Goldgur, Y., Mendoza, R. P., Stanchina, E. de, Love, T. M., Marvald, J., Xu, Y., Xu, K., Himanen, J. P., Lamminmäki, U., Veach, D., & Nikolov, D. B. (2024). Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells. Biomedicine & Pharmacotherapy, 180, 117605. https://doi.org/10.1016/j.biopha.2024.117605
Publication Date
Zirpoli, H., Bernis, M. E., Sabir, H., Manual Kollareth, D. J., Hamilton, J. A., Huang, N., Ng, J., Sosunov, S. A., Gaebler, B., Ten, V. S., & Deckelbaum, R. J. (2024). Omega-3 fatty acid diglyceride emulsions as a novel injectable acute therapeutic in neonatal hypoxic-ischemic brain injury. Biomedicine & Pharmacotherapy, 175, 116749. https://doi.org/10.1016/j.biopha.2024.116749
Publication Date
Shi, C., Huang, K., Soto, J., Sankaran, R., Kalia, V., Onwumere, O., Young, M., Einbond, L., & Redenti, S. (2023). Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles. Biomedicine & Pharmacotherapy, 161, 114554. https://doi.org/10.1016/j.biopha.2023.114554
Publication Date
Parejo-Alonso, B., Royo-García, A., Espiau-Romera, P., Courtois, S., Curiel-García, Á., Zagorac, S., Villaoslada, I., Olive, K. P., Heeschen, C., & Sancho, P. (2023). Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma. Biomedicine & Pharmacotherapy, 158, 114162. https://doi.org/10.1016/j.biopha.2022.114162
Publication Date
Wang, Z., Wang, J., Zhao, H., Zhao, T., Chen, Y., Jiang, M., Zhang, S., Wei, Y., Zhang, J., Zhou, Y., Shi, S., Fu, Z., Yang, Y., Zhang, Y., Yang, L., Que, J., & Liu, K. (2022). Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy, 153, 113309. https://doi.org/10.1016/j.biopha.2022.113309
Publication Date